116 related articles for article (PubMed ID: 25112037)
1. Call for HPV vaccine reduction.
J Fam Health Care; 2014 Jun; 24(4):6. PubMed ID: 25112037
[No Abstract] [Full Text] [Related]
2. Two doses of HPV vaccine may be sufficient.
Kuehn BM
JAMA; 2011 Oct; 306(15):1643. PubMed ID: 22009089
[No Abstract] [Full Text] [Related]
3. Three doses of HPV vaccine still recommended, for now.
BMJ; 2013 Apr; 346():f2797. PubMed ID: 23637199
[No Abstract] [Full Text] [Related]
4. Three provinces to study 2-dose HPV vaccine.
Eggertson L
CMAJ; 2007 Aug; 177(5):444-5. PubMed ID: 17724315
[No Abstract] [Full Text] [Related]
5. Who should get the HPV vaccine?
Pichichero ME
J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
[No Abstract] [Full Text] [Related]
6. HPV vaccine is safe and effective and is now routinely recommended for preteen girls and boys.
Michigan Department of Community Health
Mich Med; 2012; 111(2):24-6. PubMed ID: 22594161
[No Abstract] [Full Text] [Related]
7. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model.
Jit M; Brisson M; Laprise JF; Choi YH
BMJ; 2015 Jan; 350():g7584. PubMed ID: 25567037
[TBL] [Abstract][Full Text] [Related]
9. HPV 16/18 prevalence reduced 3 years following vaccine introduction.
Riedmann EM
Hum Vaccin Immunother; 2014; 10(2):254. PubMed ID: 24963520
[No Abstract] [Full Text] [Related]
10. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
11. HPV vaccine recommendations.
Committee on Infectious Diseases
Pediatrics; 2012 Mar; 129(3):602-5. PubMed ID: 22371460
[TBL] [Abstract][Full Text] [Related]
12. Update on Adolescent Immunizations.
Schreier R; Halady T; Bishop N; Chatterjee A
S D Med; 2016 Feb; 69(2):78-83. PubMed ID: 26999915
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery.
Holder NA; Katzenellenbogen R; Middleman AB
J Adolesc Health; 2013 Sep; 53(3):423-5. PubMed ID: 23830089
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccine: an updated position statement of the Society for Adolescent Health and Medicine.
Friedman L; Bell DL; Kahn JA; Marcell AV; Middleman AB; Rosenthal SL; Zimet GD
J Adolesc Health; 2011 Feb; 48(2):215-6. PubMed ID: 21257124
[No Abstract] [Full Text] [Related]
15. Jabs for the boys: the case for gender-neutral HPV vaccination.
Baker P
Perspect Public Health; 2016 Jan; 136(1):28-9. PubMed ID: 26702116
[No Abstract] [Full Text] [Related]
16. Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months.
Lazcano-Ponce E; Stanley M; Muñoz N; Torres L; Cruz-Valdez A; Salmerón J; Rojas R; Herrero R; Hernández-Ávila M
Vaccine; 2014 Feb; 32(6):725-32. PubMed ID: 24355090
[TBL] [Abstract][Full Text] [Related]
17. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
[TBL] [Abstract][Full Text] [Related]
18. The new HPV vaccination.
Bedford H
Community Pract; 2008 Aug; 81(8):36-7. PubMed ID: 18834017
[No Abstract] [Full Text] [Related]
19. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.
Neuzil KM; Canh DG; Thiem VD; Janmohamed A; Huong VM; Tang Y; Diep NT; Tsu V; LaMontagne DS
JAMA; 2011 Apr; 305(14):1424-31. PubMed ID: 21486975
[TBL] [Abstract][Full Text] [Related]
20. The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents.
Kreimer AR; Sherman ME; Sahasrabuddhe VV; Safaeian M
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25650316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
